Pulmonary Rehabilitation Implemented With VR for Post-COVID-19 Patients
Assessment of Depressive and Anxiety Symptoms in Post-COVID-19 Patients During In-Hospital Pulmonary Reha-bilitation With Support of Virtual Reality
1 other identifier
interventional
2,000
1 country
1
Brief Summary
Although the COVID-19 pandemic was announced almost 2 years ago, societies are still facing the effects not only of individuals but also of entire populations. Clinical symptoms in patients depending on the variant of the virus range from fever, sore throat, cough, fatigue, or gastrointestinal or neurological symptoms. Symptoms of respiratory failure also occur, as well as heart and kidney damage. Therefore, it is important to implement appropriate pulmonary rehabilitation programs to counteract the effects of the disease. The current project aims to evaluate the effectiveness of a comprehensive pulmonary rehabilitation program for patients hospitalized for SARS-CoV2 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Jan 2021
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2021
CompletedFirst Submitted
Initial submission to the registry
February 15, 2022
CompletedFirst Posted
Study publicly available on registry
February 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedMarch 4, 2022
February 1, 2022
1 month
February 15, 2022
February 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hospital Anxiety and Depression Scale
The Polish version of the Hospital Anxiety and Depression Scale (HADS) was used to assess depression and anxiety in patients. The questionnaire is considered a reliable method of assessing anxiety and depression \[15\]. The HADS questionnaire consists of 14 questions scored on a 4-point (0 to 3) scale.
10 minutes
Functional Capacity
Functional capacity assessment included exercise capacity (6-minute walk test) and lung ventilation function (spirometry).
20 minutes
Study Arms (2)
Group 1
ACTIVE COMPARATORTraditional Pulmonary Rehabilitation
Group 2
EXPERIMENTALPulmonary Rehabilitation in Virtual Reality
Interventions
An in-patients 3-week high intensity rehabilitation program, five times a week, was used as the intervention treatment. The author's pulmonary rehabilitation program was programmed based on previous experience in patients with COPD. A holistic pulmonary rehabilitation program with combined treatment focused on increasing exercise capacity, restoring lung function, and supporting mental health, developed by a multidisciplinary team, was introduced. Based on the patient's submaximal exercise tolerance test results, the qualification for one of the respiratory physiotherapy models differing in therapy intensity was performed. Rehabilitation models included exercise capacity training on a cycle ergometer, breathing exercises, general fitness exercises, resistance training, and relaxation.
Eligibility Criteria
You may qualify if:
- Individuals hospitalized for COVID-19.
You may not qualify if:
- Failure to consent to participate in research,
- pneumonia,
- evidence of ischemic heart disease/acute changes on ECG,
- uncontrolled hypertension,
- insulin dependent diabetes mellitus,
- inability to exercise independently or musculoskeletal/neurological conditions that would prevent completion of the course,
- lung cancer,
- cognitive disorders, or Mini-Mental State Examination \< 24.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MSWiA Specialist Hospital in Głuchołazy
Głuchołazy, Opole Voivodeship, 48-340, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2022
First Posted
February 16, 2022
Study Start
January 1, 2021
Primary Completion
February 2, 2021
Study Completion
September 1, 2022
Last Updated
March 4, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share
Data will not be available.